The 6-month drug survival rate in patients with rheumatoid arthritis treated with tofacitinib. Ann Med Res [Internet]. 2021 Jul. 14 [cited 2025 Apr. 26];28(7):1332-5. Available from: http://annalsmedres.org/index.php/aomr/article/view/3844